financetom
Business
financetom
/
Business
/
Cathie Wood Sells $41 Million Worth Of Palantir Shares Following Post-Earnings Plunge
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cathie Wood Sells $41 Million Worth Of Palantir Shares Following Post-Earnings Plunge
May 26, 2025 2:27 AM

On Tuesday, Cathie Wood‘s Ark Invest made significant trades, notably selling shares of Palantir Technologies Inc. ( PLTR ) . This move comes after Palantir’s stock faced pressure despite surpassing first-quarter earnings expectations.

The Palantir Trade saw Ark Invest’s ARK Innovation ETF sell 376,874 shares of the AI-focused company. The trade was valued at $41.03 million. On Tuesday, Palantir ( PLTR ) shares closed 12.05% lower at $108.86.

This decision followed Palantir’s recent earnings report, which, despite exceeding analyst predictions, led to a stock decline. The stock’s drop is attributed to high investor expectations. Palantir’s shares have surged 332% over the past year and 45% year-to-date, yet the post-earnings dip highlights market volatility.

Analysts remain divided on Palantir’s future. Some view it as a key player in the AI sector, predicting a potential $1 trillion market cap within three years. However, others, like Jefferies’ Brent Thill, express skepticism about institutional interest, emphasizing its retail-driven nature.

Palantir ( PLTR ) remains Ark’s second-largest holding, accounting for approximately 8.14% of the firm’s portfolio by weight, with a total value of $421.65 million.

Other Key Trades:

Personalis Inc. — Ark Invest’s ARKG ETF acquired 318,741 shares.

Guardant Health Inc. — 237,374 shares were purchased by ARKK.

Twist Bioscience Corp. — ARKK bought 283,186 shares.

Natera Inc. — 55,623 shares were added to ARKK.

GitLab Inc. — 30,107 shares were acquired by ARKK.

Want to know about other buzzing AI Stocks? Benzinga Edge Stock Rankings has you covered. Click here to find out more.

Read Next: 

Warren Buffett Expresses Disappointment Over Dollar Depreciation: Don’t Want To Own Assets In A Currency That Is ‘Really Going To Hell’

This story was generated using Benzinga Neuro and edited by Shivdeep Dhaliwal

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Southwest Airlines would need different aircraft if launching flights to Europe, CEO says
Southwest Airlines would need different aircraft if launching flights to Europe, CEO says
Sep 9, 2025
WASHINGTON, Sept 9 (Reuters) - U.S. low-cost carrier Southwest Airlines ( LUV ) would need different aircraft if it were to launch flights to Europe, CEO Bob Jordan told a Washington D.C. gathering of aerospace executives on Tuesday. Southwest ( LUV ), which operates mostly domestic flights with a fleet of Boeing 737 jets, has been struggling to find its...
Chevron to boost Vaca Muerta output to 30,000 bpd by year-end
Chevron to boost Vaca Muerta output to 30,000 bpd by year-end
Sep 9, 2025
BUENOS AIRES, Sept 9 (Reuters) - Chevron ( CVX ) plans to increase oil production in Argentina's Vaca Muerta shale formation to 30,000 barrels per day by the end of the year, a company executive said on Tuesday. Speaking at the Argentina Oil and Gas conference in Buenos Aires, the executive said the country needs a stable regulatory environment and...
Johnson & Johnson's Inlexzo to Treat Bladder Cancer Receives FDA Approval
Johnson & Johnson's Inlexzo to Treat Bladder Cancer Receives FDA Approval
Sep 9, 2025
04:51 PM EDT, 09/09/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said the US Food and Drug Administration approved Inlexzo, formerly known as TAR-200, to treat certain types of bladder cancer. The approval was supported by data from a Phase 2b clinical study, which showed 82% of patients with Bacillus Calmette-Guerin-unresponsive non-muscle invasive bladder cancer achieved a complete...
Southwest Airlines would need different aircraft if launching flights to Europe, CEO says
Southwest Airlines would need different aircraft if launching flights to Europe, CEO says
Sep 9, 2025
WASHINGTON (Reuters) -U.S. low-cost carrier Southwest Airlines would need different aircraft if it were to launch flights to Europe, CEO Bob Jordan told a Washington D.C. gathering of aerospace executives on Tuesday. Southwest, which operates mostly domestic flights with a fleet of Boeing 737 jets, has been struggling to find its footing after the COVID pandemic. Its lackluster earnings have...
Copyright 2023-2026 - www.financetom.com All Rights Reserved